Author: Mintel Group Ltd.
Last saved by: HTTP server

Cold and Flu Remedies - UK - September 2008

ISSUES IN THE MARKET
Main report themes
Definition
INSIGHTS AND OPPORTUNITIES
Building immunity
If not for health, try vanity
Macho men
MARKET IN BRIEF
Sales warm up
Decongestants unblock the market
Loyal to the brand
The future
FAST FORWARD TRENDS
Fast forward, an explanation
 TREND 1. BRAND EXPERIENCE
What's it about?
What we've seen
Specifics
Implications
What’s next – the complete cure
 TREND 2. HOME OF THE SENSES
What's it about?
What we've seen
Specifics
Implications
What’s next – how clean is your house?
INTERNAL MARKET ENVIRONMENT
Key points
The cold and flu facts
No cure
Market going cold?
Flu has flown?
Figure 1: Selected minor ailments suffered from in the last 12 months, GB, 2003-07
OTC going TTFN?
Figure 2: Action taken when suffering from flu with a slight temperature, 2004-07
Snubbing sickness
Figure 3: Attitudes towards health, 2003-07
Sales restrictions
BROADER MARKET ENVIRONMENT
Key points
Premium potential
Figure 4: Forecast adult population trends, by socio-economic group, 2003-13
A greying population
Figure 5: Structure of the UK population, by gender and age, 2003-13
Infancy of the infant market
Blame it on the weather
Figure 6: Mean winter temperature, UK, 2003/04-2007/08
When it rains, sales soar
Figure 7: Summer rainfall, UK, 2003-07
Deseasonalising the decongestant
COMPETITIVE CONTEXT
Key points
In context
Figure 8: Market value of OTC pharmaceuticals, 2003-07
 PREVENTATIVE MEASURES
The flu jab
Meeting targets
Vitamins and minerals
Figure 9: Vitamin intake, 2003-07
The science of supplements
 ALTERNATIVE TREATMENTS
Complementary medicines
Analgesics
Cough and throat remedies
STRENGTHS AND WEAKNESSES IN THE MARKET
Strengths
Weaknesses
WHO’S INNOVATING?
Key points
Up, up and away
Figure 10: Number of new product launches, 2003-07
Powder or pills
No time to stop
Autumn/winter 2007
Targeting specifics
Decongestants move outside the box
Preventative action
Further afield for future trends
MARKET VALUE AND FORECAST
Key points
Reaching fever pitch
Figure 11: UK retail sales of cold and flu remedies and decongestants, 2003-13
Driving value through all-in-one…
…but some dampening of growth by own-label
The future lies in fast-acting products
 FORECAST
Factors used in forecast
SEGMENT PERFORMANCE
Key points
Decongestants in the driving seat
Figure 12: UK retail sales of cold and flu remedies and decongestants, by sector, 2003-08
 COLD AND FLU REMEDIES
All-in-one relief for colds and flu
Figure 13: UK retail sales of cold and flu remedies, 2003-13
The value of innovation
Brands need remedy to own-label
Format choices
Figure 14: UK retail sales of cold and flu remedies, by type, 2006-08
Feeling hot, hot, hot
Captivated by capsules
Tablets teeter
Liquids for little-uns
Out in the cold
 DECONGESTANTS
Decongestants tackle hayfever
Figure 15: UK retail sales of decongestants, 2003-13
Format choices
Figure 16: UK retail sales of decongestants, by type, 2006-08
A topical issue
MARKET SHARE
Key points
 COLD AND FLU REMEDIES
Lemsip leads the way
Figure 17: Manufacturers’ brand shares in cold and flu remedies, 2006 and 2008
The own-label offering
 DECONGESTANTS
Victory for Vicks
Figure 18: Manufacturers’ brand shares in decongestants, 2006 and 2008
COMPANIES AND PRODUCTS
Key points
Figure 19: Brand map of the UK cold and flu market, 2008
Reckitt Benckiser
Lemsip
Karvol
Nurofen
GlaxoSmithKline
Beechams
Night Nurse/Day Nurse
Breathe Right
Johnson & Johnson
Benylin
Sudafed
Calpol
Procter & Gamble
Vicks
Novartis
Otrivin
Thornton & Ross
G R Lane Health Products
Olbas
Own-label manufacturers
BRAND ELEMENTS
 BRAND MAP
Figure 20: Attitudes and usage of cold and flu remedy brands, July 2008
 LEMSIP
What the brand is trying to achieve.
What the consumer thinks
Figure 21: Attitudes towards the Lemsip brand, July 2008
 NIGHT NURSE
What the brand is trying to achieve.
What the consumer thinks
Figure 22: Attitudes towards the Night Nurse brand, July 2008
 VICKS
What the brand is trying to achieve.
What the consumer thinks
Figure 23: Attitudes towards the Vicks brand, July 2008
 SUDAFED
What the brand is trying to achieve.
What the consumer thinks
Figure 24: Attitudes towards the Sudafed brand, July 2008
 OLBAS
What the brand is trying to achieve.
What the consumer thinks
Figure 25: Attitudes towards the Olbas brand, July 2008
 BRAND QUALITIES OF COLD AND FLU REMEDY BRANDS
Lemsip most caring and safest, but Beechams has expertise
Figure 26: Personalities of various cold and flu remedy brands, July 2008
 EXPERIENCE OF COLD AND FLU REMEDY BRANDS
Lemsip most popular, but Beechams and Vicks close behind
Figure 27: Consumer usage of various cold and flu remedy brands, July 2008
 BRAND INTENTIONS FOR COLD AND FLU REMEDY BRANDS
Johnson & Johnson snubbed, Lemsip again dominating into the future
Figure 28: Consideration of various makeup brands, July 2008
 BRAND MOMENTUM FOR COLD AND FLU REMEDY BRANDS
Lemsip leads cold comfort for the rest.
Figure 29: Momentum of various cold and flu remedy brands, July 2008
 BRAND MOTIVATION FOR COLD AND FLU REMEDY BRANDS
Lemsip leads for cold and flu, Vicks and Olbas joint for decongestant
Figure 30: Momentum of various cold and flu remedy brands, July 2008
 BRAND SATISFACTION FOR COLD AND FLU REMEDY BRANDS
Lemsip just beaten for positive endorsement, but Olbas most excellent
Figure 31: Satisfaction with various cold and flu remedy brands, July 2008
 BRAND COMMITMENT TO COLD AND FLU REMEDY BRANDS
Lemsip is most preferred and recommended
Figure 32: Commitment to various cold and flu remedy brands, July 2008
 ROUND UP
BRAND COMMUNICATION AND PROMOTION
Key points
Speculate to accumulate
Figure 33: Main monitored media advertising expenditure on OTC cold and flu remedies and decongestants, 2003-08
The power of four
Figure 34: Main monitored media advertising expenditure on cold and flu remedies*, by advertiser, 2003-07
Education vs emotion
Below-the-line activity
CHANNELS TO MARKET
Key points
Grocers match chemists
Figure 35: UK retail sales of cold and flu remedies and decongestants, by outlet type, 2006-08
Megalomultiples
Reaction and pro-action
THE CONSUMER – USAGE FREQUENCY AND FORMAT
Key points
 USAGE FREQUENCY
Treating the sniffles
Figure 36: Usage of cold and flu remedies in the last 12 months, 2003-07
Don’t stop moving
 FORMAT
Tablets top the table
Figure 37: Format of remedy used to treat cold and flu, February 2008
Figure 38: Format of remedy used to treat cold and flu, by demographic profile, February 2008
The basic tablet
Powders – an old favourite
Lads like capsules
Lozenges
Vapour rub – a family choice
Down in one
THE CONSUMER – WHAT CONSUMERS ARE LOOKING FOR
Key points
Trust in brands
Figure 39: Key features looked for when buying cold/flu remedies, February 2008
The need for speed
A measure of strength
All for one
The format factor
Under the influence?
THE CONSUMER – CONSUMER ATTITUDES AND BEHAVIOUR
Key points
Failing to treat
Figure 40: Consumer attitudes and behaviour about treating colds and the flu, February 2008
Taking immediate action
General relief
Prevention is better than a cure
Seeking advice
THE CONSUMER – FURTHER ANALYSIS
Key points
 NUMBER OF COLD AND FLU REMEDIES USED
Figure 41: Number of types of cold and flu treatments used, February 2008
One type
Figure 39: Features looked for when buying remedies amongst those who use one type of cold/flu treatment, February 2008
Who are they?
Next steps
Two types
Who are they?
Next steps
Three or more types
Who are they?
Next steps
 CONSUMER TYPOLOGIES
Figure 42: Consumer typologies, February 2008
Takers (12% of sample)
Who are the Takers?
Figure 43: Consumer typologies, by use of remedies, February 2008
Marketing message
The Medicated (17% of sample)
Who are the Medicated?
Figure 44: Consumer typologies, by response to going to the GP for advice, February 2008
Marketing message
The Healthy Pre-emptors (19% of sample)
Who are The Healthy Pre-emptors?
Marketing message
The Sufferers (52% of sample)
Who are the Sufferers?
Marketing message
APPENDIX
Advertising data
Abbreviations
APPENDIX – INTERNAL MARKET ENVIRONMENT
Figure 45: Market value of OTC pharmaceuticals, 2003-07
APPENDIX – BRAND COMMUNICATION – DETAILED BREAKDOWN
Figure 46: Main monitored media advertising expenditure on cold and flu remedies, by advertiser and brand, 2003-08*
APPENDIX – THE CONSUMER – USAGE FREQUENCY AND FORMAT
Figure 47: When used, frequency of using cold and flu remedies, by demographic sub-group, 2007
Figure 48: Usage of cold and flu remedies in the last 12 months, by action taken when suffering from flu with a slight temperature, 2007
 FORMAT
Figure 49: Format of remedy used to treat cold and flu, by demographic sub groups, February 2008
Figure 50: Format of remedy used to treat cold and flu, by demographic sub groups, February 2008
APPENDIX – THE CONSUMER – WHAT CONSUMERS ARE LOOKING FOR
Figure 51: Key features looked for when buying cold/flu remedies, by demographic sub groups, February 2008
Figure 52: Key features looked for when buying cold/flu remedies, by demographic sub group, February 2008
APPENDIX –CONSUMER ATTITUDES AND BEHAVIOUR
Figure 53: Consumer attitudes and behaviour towards treating colds and flu, by demographic sub group, February 2008
Figure 54: Consumer attitudes and behaviour towards treating cold and the flu, by demographic sub group, February 2008
APPENDIX – THE CONSUMER – FURTHER ANALYSIS
Number of cold and flu remedies used
Figure 55: Cold and flu treatments usage repertoire, February 2008
Figure 56: Cold and flu treatments usage repertoire, by attitudes towards cold and flu remedies, February 2008
Figure 57: Cold and flu treatments usage repertoire, by features looked for in purchase, February 2008
Figure 58: Cold and flu treatments usage repertoire, by demographic sub-group, February 2008
Consumer typologies
Figure 59: Repertoires, by consumer typologies, February 2008
Figure 60: Consumer typologies, by types of cold and flu treatments used, February 2008
Figure 61: Consumer typologies, by features looked for when buying remedies, February 2008
Figure 62: Consumer typologies, by demographic sub group, February 2008

This report is supplied in accordance with Mintel's terms and conditions.  
© Mintel Group Ltd.